polarean Share News (POLX)

IN BRIEF: Polarean Imaging widens annual loss as selling costs surge

Polarean Imaging PLC - London-based medical‑imaging technology - For 2021, annual loss widens to USD14.0 million from USD6.5 million in 2020. Revenue edges upwards to USD1.2 million from USD1.1 million. Selling & distribution expenses surge to USD5.6 million from USD917,783 in 2020.

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: Zephyr, TransGlobe sales up; DeepMatter wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Polarean inks long Covid research deal with Oxford NHS trust

(Sharecast News) - Medical imaging technology company Polarean announced a research collaboration with Oxford University Hospitals NHS Foundation Trust (OUH) on Wednesday, to study the long-term effects of Covid-19 in patients with breathing difficulties months after initial infection.

IN BRIEF: Polarean Imaging promotes Ken West to board chair

Polarean Imaging PLC - London-based medical‑imaging technology - Promotes Non-Executive Director Ken West to chair, effective immediately. West, who has been with Polarean for nine years, replaces Jonathan Allis, who is retiring. Also hires Dan Brague as a non-executive director. Brague most recently was chief executive officer for North America at Curium Pharma, a London-based nuclear medicine company.

IN BRIEF: Polarean Imaging wins new system order for xenon polariser

Polarean Imaging PLC - North Carolina-based MRI equipment and medical-imaging technology company - Says it has received an additional research unit order for a Xenon Polariser 9820. Says system will be installed in the Center for Pulmonary Imaging Research at the Cincinnati Children's Medical Center. Company holds a Small Business Innovation Research grant with the Cincinnati Children's Center, awarded by the National Heart, Lung & Blood Institute in April 2017.

Polarean Imaging receives research order from long-standing partner

(Sharecast News) - Medical imaging technology company Polarean Imaging has received an additional research unit order for a xenon polariser '9820', it announced on Monday.

TRADING UPDATES: Tatton assets grow; Intosol needs funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

FDA accepts Polarean's medical imaging drug-device resubmission

(Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on its investigational drug‑device combination product on Wednesday, which uses hyperpolarised '129Xenon' gas to enhance magnetic resonance imaging (MRI) in pulmonary medicine.

TRADING UPDATES: SSE's Transmission raises cash; Croda gets UK grant

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

TRADING UPDATES: CentralNic expects revenue growth ahead of views

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Polarean installs xenon polariser system at Vancouver hospital

(Sharecast News) - Medical imaging technology company Polarean Imaging announced the installation of its 9820 xenon polariser system at BC Children's Hospital in Vancouver on Monday.

IN BRIEF: Polarean installs system in children's hospital in Vancouver

IN BRIEF: Polarean installs system in children's hospital in Vancouver

TRADING UPDATES: Galliford signs LHC deal; Polarean turned down by FDA

TRADING UPDATES: Galliford signs LHC deal; Polarean turned down by FDA

TRADING UPDATES: Sharp profit performance from Gem Diamonds, Headlam

TRADING UPDATES: Sharp profit performance from Gem Diamonds, Headlam